In non-responders (defined as a best response of PD), the NLR at 4 weeks tended to be higher than that at baseline; however, the difference did not reach statistical significance (Fig. 1 ).
← all excerpts
The neutrophil-lymphocyte ratio has a role in predicting the effectiveness of nivolumab in Japanese patients with metastatic renal cell carcinoma: a multi-institutional retrospective study.
1
—
—